Literature DB >> 575446

Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness.

L W Laughlin, J M Meegan, L J Strausbaugh, D M Morens, R H Watten.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 575446     DOI： 10.1016/0035-9203(79)90006-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  91 in total

1.  Genetic reassortment of Rift Valley fever virus in nature.

Authors:  A A Sall; P M Zanotto; O K Sene; H G Zeller; J P Digoutte; Y Thiongane; M Bouloy
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds.

Authors:  S Garcia; J M Crance; A Billecocq; A Peinnequin; A Jouan; M Bouloy; D Garin
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Use of reverse transcriptase PCR in early diagnosis of Rift Valley fever.

Authors:  A A Sall; E A Macondo; O K Sène; M Diagne; R Sylla; M Mondo; L Girault; L Marrama; A Spiegel; M Diallo; M Bouloy; C Mathiot
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

4.  Ngari virus is a Bunyamwera virus reassortant that can be associated with large outbreaks of hemorrhagic fever in Africa.

Authors:  Sonja R Gerrard; Li Li; Alan D Barrett; Stuart T Nichol
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies.

Authors:  T G Besselaar; N K Blackburn
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

6.  The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins.

Authors:  T G Besselaar; N K Blackburn
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

7.  Using a field quantitative real-time PCR test to rapidly identify highly viremic rift valley fever cases.

Authors:  M Kariuki Njenga; Janusz Paweska; Rose Wanjala; Carol Y Rao; Matthew Weiner; Victor Omballa; Elizabeth T Luman; David Mutonga; Shanaaz Sharif; Marcus Panning; Christian Drosten; Daniel R Feikin; Robert F Breiman
Journal:  J Clin Microbiol       Date:  2009-01-26       Impact factor: 5.948

8.  Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus.

Authors:  K Keegan; M S Collett
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

Review 9.  Novel infectious agents causing uveitis.

Authors:  Moncef Khairallah; Soon Phaik Chee; Sivakumar R Rathinam; Sonia Attia; Venu Nadella
Journal:  Int Ophthalmol       Date:  2009-08-27       Impact factor: 2.031

10.  A statistical model of Rift Valley fever activity in Egypt.

Authors:  John M Drake; Ali N Hassan; John C Beier
Journal:  J Vector Ecol       Date:  2013-12       Impact factor: 1.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.